Global Ganja Report

In the big — and, in nearly half of US states now, successful — drive to legalize cannabis, two major arguments have been brought to bear. First, that public oversight of a legal industry will assure transparency and standards for quality. And secondly, that a taxed industry will be a boon to state and local economies.

But now a disturbing new study from an industry advocacy group in California indicates that the legal cannabis sector faces a challenge in the proliferation of ostensibly legal but in fact unregulated psychoactive “hemp” products.

In the ultimate imprimatur of mainstream acceptance, the 10th annual Cannabis World Congress & Business Expo was held June 5-6 in Manhattan’s Javits Convention Center, the Big Apple’s premier venue for trade shows and industry confabs. And the event had the open participation of New York city and state government agencies, as well as capitalist enterprises from around the country and the planet.

Rights for medicinal cannabis users in the workplace have not kept pace with the law in states that have embraced medical and even “recreational” use. Now a case in Vermont may push state and federal authorities alike to close the loopholes that allow workers to be dismissed—and denied unemployment insurance—for using state-legal medicine.

Small producers have long been wary of the cannabis industry coming under domination by multi-state operators with the worst practices of corporate America. But the revelations of Russian oligarch money in the coffers of leading MSO Curaleaf appear to vindicate even the most cynical observers. These follow a slew of controversies concerning product safety and labor rights at the company.

Industrial-scale illicit cannabis grow operations are being raided by police in Southern Oregon. Licit-market prices are totally depressed in Oregon, yet the illicit market continues to be evidently lucrative. What explains this contradiction, and what can be done?

Authorities in southern Oregon are making accusations of criminal labor and environmental practices by illicit cannabis growers—and carrying out militarized raids. The grim headlines are starting to make legalization in the Beaver State look like something of Pyrrhic victory.

Alabama's Gov. Kay Ivey signed a bill May 17 legalizing the use of medical cannabis products in the state—on strictly limited terms. The new law, coming after decades of Republican opposition, allows use of extracts, tinctures, tablets or gel cubes—but not herbaceous flower, or any other products that can be smoked or vaped. Edibles such as cookies or candies are also barred.

Gains are reported from Massachusetts in organized labor's push to unionize the cannabis industry. But significant obstacles remain—from management roadblocking, to the ambiguous status under national labor law of an industry dealing in a federally illegal substance.